tradingkey.logo
tradingkey.logo
Pesquisar

Bio Rad Laboratories Inc

BIOb
Adicionar à lista de desejos
321.500USD
+25.010+8.44%
Fechamento 06/26, 16:00ETCotações atrasadas em 15 min
8.63BValor de mercado
53.32P/L TTM

Mais detalhes de Bio Rad Laboratories Inc Empresa

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Informações de Bio Rad Laboratories Inc

Código da empresaBIOb
Nome da EmpresaBio Rad Laboratories Inc
Data de listagemMar 17, 1980
CEOSchwartz (Norman D)
Número de funcionários7700
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 17
Endereço1000 Alfred Nobel Dr
CidadeHERCULES
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal94547
Telefone15107247000
Sitehttps://www.bio-rad.com/
Código da empresaBIOb
Data de listagemMar 17, 1980
CEOSchwartz (Norman D)

Executivos da empresa Bio Rad Laboratories Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
431.47K
+13.21%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
--
--
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
--
--
Mr. Edward Chung
Mr. Edward Chung
Vice President - Investor Relations
Vice President - Investor Relations
--
--
Ms. Allison Schwartz
Ms. Allison Schwartz
Director
Director
--
--
Mr. Roop K. Lakkaraju
Mr. Roop K. Lakkaraju
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
--
--
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
431.47K
+13.21%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
--
--
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
--
--
Mr. Edward Chung
Mr. Edward Chung
Vice President - Investor Relations
Vice President - Investor Relations
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Bio Rad Laboratories Inc?

Os cinco principais acionistas de Bio Rad Laboratories Inc são: Mr. Norman D. Schwartz

Quantas instituições possuem ações da Bio Rad Laboratories Inc (BIOb)?

Em 2026Q1, 13 instituições possuíam ações da Bio Rad Laboratories Inc, com valor de mercado aproximado de 3.75K, representando 0.07% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -232.00.
KeyAI